News and Comments

Biotechnology Companies: A Model that’s Gaining Visibility

  Tuesday, December 07, 2010

The biotechnology company model founded on management skills rather than purely on scientific skills has begun to gain investors’ appreciation. The reason is that many firms built around skilled, experienced entrepreneurs have succeeded in bringing a large number of drugs to the market and in marketing them competently. These firms license or acquire drugs in mid-or late-phase trials. They sometimes acquire therapeutic molecules in early-stage development only if these molecules prove to have optimal affinity on validated proteins in pathways of diseases, and produce desired agonist or antagonist effects. In order to select the products that can be called breakthroughs, the most successful of the firms established and run by entrepreneurs with strong business acumen employ specialists in pharmaceutical sciences and in clinical trials. These scientists have experience in sensitive areas such as drug development, clinical trials, medicinal chemistry, and other important disciplines required for drug discovery, development and testing.   More...


Recent Postings


Archive


Tags

Zerenex Xoma (XOMA) Multiple Myeloma ABBVIE (ABBV) VANDA (VNDA) Array Pharmaceuticals (ARRY) Seattle Genetics (SGEN) Rapamune Benlysta (belimumab) Pluristem (PSTI) Sanofi-Aventis (SAN) Micromet (MITI) Cytokinetics (CYTK) TOKAI (TKAOI) Merck (MRK) Anacor (ANAC) Mirati Therapeutics (MRTX) IDERA (IDRA) NANTKWEST (NK) GlaxoSmithKline (GSK) NEKTAR (NKTR)) Prolor Biotech (PBTH) CompuGen (CGEN) ZALTRAP™ Telaprevir Idenix (IDIX) Intrexon (XON) ARCA (ABIO) OSI (OSIP) Vertex (VRTX) Elan (ELN) Intercept (ICPT) Agenus (AGEN BIOMARIN (BMRN) HALOZYME (HALO) Abbott Laboratories (ABT) Exelixis (EXEL) Biogen Idec (BIIB) Trastuzumab-DM1 Ridaforolimus Valeant Pharmaceuticals International (VRX) Alnylam (ALNY) Galena (GALE) Aimmune Therapeutics (AIMT) ADVENTRIX (ANX) Roche (RHHBY) Illumina (ILMN) KITE (KITE) Sanofi (SNY) Anadys (ANDS) KERYX (KERX) Inovio (INO) SERES THERAPEUTICS (MCRB) Intermune (ITMN) Amgen (AMGN) Sequenom (SQNM) GUARDIAN HEALTH C4 Therapeutics AERIE PHARMACEUTICALS Bristol-Myers Squibb (BMY) Regeneron (REGN) Prosensa (RNA) Biocryst (BCRX) Revlimid (lenolidamide) Agenus (AGEN) Sangamo (SGMO) JUNO (JUNO) ISIS (ISIS) Roche (ROCHE) Theravance (THRX) Ariad (ARIA) Genentech ImmunoGen (IMGN) Sarepta (SRPT) Herceptin Gilead (GILD) Sanofi (SNA) Jazz Pharmaceuticals (JAZZ) Dynavax (DVAX) Auspex (ASPX) Endometrial Cancer Onyx (ONXX) Dendreon (DNDN) SYNTA (SNTA) SUNESIS PHARMACEUTICALS (SNSS) Ziofpharm (ZIOP) galapagos (GLPG) Tysabri Velcade (bortezomib) Incyte (INCY) Human Genome Sciences (HGSI)